Skip to main content
OpenTrials
Completed

NCT Number: NCT06267326

World Health Organization (WHO) , COVID19 Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

Objectives: identify and recognize clinical Characteristics, Pathophysiology, and management of a group of patients with rhino Rhino-Orbito-Cerebral Mucormycosis infection associated with Covid 19 viral infection

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Mucormycosis; Rhinocerebral (Etiology) Bacterial Infections and Mycoses COVID-19 Coronaviridae Infections Coronavirus Infections Infections Lung Diseases Mucormycosis Mycoses Nidovirales Infections Pneumonia Pneumonia, Viral RNA Virus Infections Respiratory Tract Diseases Respiratory Tract Infections Virus Diseases Zygomycosis

Age range

22 year–77 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 1 / Phase 2

Primary location

Omar Elmonofy

Cairo, Egypt

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • all patients with mucormycosis post covid 19

Exclusion criteria

  • The patient not suffered from covid 19

Treatment and study plan

debridment

Procedure

resection of dead bone

Other names: medication

Primary outcomes

  1. 35 patients suffering from mucormycosis infection post covid 19

    Time frame: 2 years

    Ratio Scale. Visual Analog Score for pain Ratio Scale. Ratio Scale. ratio scale

  2. 25 patients were cured with comorbidity and 10 pateints died

    Time frame: 2 years

    ordinal scale Visual Analog Score for pain

  3. pain

    Time frame: two years

    Visual Analog Score for pain

Secondary outcomes

  1. Visual Analog Score for pain

    Time frame: 2years

    pain

Sponsors and collaborators

Lead sponsor

Nasser Institute For Research and Treatment

Other Gov

Registry information

Official study title

Case Series of Post Covid 19 Rhino Orbito Cerebral Mucormycosis in Egypt

Important dates

Study start
2021
Primary completion
2022
Study completion
2023
First posted
Feb 20, 2024
Registry last updated
Feb 20, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.